HSS Medical Supply will distribute Abbott's ID NOW rapid molecular testing platform, expanding point-of-care diagnostics.
A clinical trial found that twice-per-pregnancy STI screening reduced preterm birth risk by 23% versus standard care.
Researchers developed a blood test using 10 biomarkers to help predict chronic disease risk and functional decline in adults.
A study found HPV testing detected high-grade cervical lesions missed by cytology in a cohort screened with CoSara’s assay.
A new Pennsylvania law mandates no-cost coverage of blood-based colorectal cancer screening for 2 million residents, aligning ...
OGT releases an RNA-based NGS panel for AML, enabling detection of leukemia-associated gene fusions at 1% tumor cell levels.
Malignant mesothelioma is a rare, life-threatening cancer that develops in the thin tissue lining internal organs, with more ...
Curiox Biosystems expands its leadership team and forms a Strategic Advisory Board to support growth of its centrifuge-free ...
FDA grants bioMérieux dual clearance and CLIA waiver for the BIOFIRE SPOTFIRE Vaginitis Panel, a rapid 20-minute ...
Path Fertility secures $2 million NIH grant to develop and validate a semen-based epigenetic assay for NOA and cancer risk.
FDA clears Sekisui Diagnostics’ rapid combo test for COVID-19 and flu A&B, offering CLIA-waived, 510(k)-cleared pathogen ...
Twist Bioscience launches Twist MRD Express, offering custom molecular residual disease panels with turnaround times starting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results